Nuvera’s Takeaways from CBI’s 10th Hub and SPP Model Optimization Conference

CBI hosted their 10th Hub and SPP Model Optimization Conference on February 27-28 in historic Philadelphia, PA. Nuvera was proud to be both a sponsor and presenter at this year’s conference, but what was unique was the opportunity we had to share the stage and co-present with one of our clients, Insmed, a case study titled “Patient Experience in Rare Disease: From Concept to Capability.” The presentation highlighted:

  • The importance of understanding the greatest needs of both the patient and HCP and where the manufacturer can make the greatest impact throughout the treatment journey; ensuring the support and services provided are aligned with addressing key challenges
  • How engaging in “co-creation” with patients and HCPs can improve the manufacturers understanding of their customers and ensure support program goals are met
  • Significance of a thorough planning process on making the proper investment decisions for improved patient access

It was an honor to be able to share the stage with one of our valued clients and recount the best practices and outcome of one of our recent engagements.

Along with our presentation CBI focused their agenda on breakthrough strategies for service model design and enhancement to improve access and outcomes. Some sessions we found to be most impactful included:

  • Legal and Regulatory Environment – Compliance with applicable laws is important to patient service design, while understanding ‘intent of the services’ is a driving factor for enforcement. A panel of industry experts from the US Attorney’s Office and AbbVie provided perspective to the attendees on how to remain amenable to these laws, including, but not limited to:
    • Ensuring appropriate consents are obtained for both the patient and their caregiver
    • Transparency of all program elements and ease of opt-out (initially and once enrolled)
    • Enabling monitoring of programs in order to identify outliers and ensure consistency with SOPs and call guides
  • Specialty Pharmacy Trends – Information presented focused in two key areas:
    • Picking an SPP Committed to Accreditation: There are a number of accrediting agencies that have been created to assess SPP capabilities. The importance of selecting SPP partners that are committed to meeting the accreditation standards was highlighted when designing and managing SPP networks.
    • Adapting Co-Pay Support as Payers Evolve: There is a growing trend around ‘co-pay card accumulators or coupon adjustments’ that is having an impact on patient out-of-pocket and manufacturer costs. This is an important area to continue to monitor to understand the financial implications for manufacturers and affordability and adherence for patients – especially those in high-deductible plans
  • Leveraging Emerging Technology in Patient Services – Technology advancements are being implemented to help improve the efficiency and quality of service delivery. Electronic prescribing and electronic Prior Authorization (ePA) have made strong advancements in recent years. However, areas such as electronic benefits verification (eBV) and connection with EMR systems continue to lag due to the complex and heterogeneous US healthcare system. As patients continue to face increasing levels of complexly in obtaining their care and coverage speed to product access becomes that much more paramount. Additionally, providers are undertaking more risk-based reimbursement and, therefore, want to ensure they have the right systems in place to ensure accurate payment. Identifying and implementing appropriate technology-based solutions to speed the process, increase accuracy and boost quality is the goal of manufacturers, their Hubs, SPPs, Providers, and Payers.

CBI’s 10th Hub and SPP Model Optimization Conference provided a forum for over 200 industry stakeholders to share and exchange ideas on ways to continuously improve the patient experience.

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit

Recommended Posts

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *